{"product_id":"8th-annual-symposium-contemporary-management-of-cardiovascular-disease-in-women-2025","title":"8th Annual Symposium Contemporary Management of Cardiovascular Disease in Women 2025","description":"\u003ch2\u003eContemporary Management of Cardiovascular Disease in Women 2025\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e8th Annual Symposium | Gender-Specific Cardiology Updates \u0026amp; Clinical Strategies\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e📌 Overview\u003c\/h3\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe \u003cstrong\u003e8th Annual Symposium on Contemporary Management of Cardiovascular Disease in Women 2025\u003c\/strong\u003e is a comprehensive, evidence-based program focused on the \u003cstrong\u003eunique aspects of cardiovascular disease in women\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis course explores \u003cstrong\u003esex-specific differences in diagnosis, treatment, and outcomes\u003c\/strong\u003e, addressing gaps in care and equipping clinicians with the knowledge needed to deliver more equitable and effective cardiovascular care.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e📦 Course Specifications\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e🎥 \u003cstrong\u003eFormat:\u003c\/strong\u003e Video lectures only (no PDFs)\u003c\/li\u003e\r\n \t\u003cli\u003e📅 Course Year: 2025\u003c\/li\u003e\r\n \t\u003cli\u003e🧠 Level: Intermediate to Advanced\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e🎯 Target Audience\u003c\/h3\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis course is ideal for:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCardiologists\u003c\/li\u003e\r\n \t\u003cli\u003eInternal medicine physicians\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary care physicians\u003c\/li\u003e\r\n \t\u003cli\u003eNurse practitioners \u0026amp; physician assistants\u003c\/li\u003e\r\n \t\u003cli\u003eNurses and pharmacists involved in cardiovascular care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e🧠 What You Will Learn\u003c\/h3\u003e\r\n\u003ch4\u003e❤️ Epidemiology \u0026amp; Risk in Women\u003c\/h4\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eUnique cardiovascular risk factors in women\u003c\/li\u003e\r\n \t\u003cli\u003eUnder-recognition and disparities in care\u003c\/li\u003e\r\n \t\u003cli\u003eUpdated ASCVD risk assessment strategies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e🫀 Cardiovascular Conditions in Women\u003c\/h4\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCoronary artery disease (CAD) in pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eHeart failure and hypertrophic cardiomyopathy\u003c\/li\u003e\r\n \t\u003cli\u003eAtrial fibrillation and cardiac amyloidosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e🩺 Valvular \u0026amp; Aortic Disease\u003c\/h4\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSex differences in valve repair and replacement\u003c\/li\u003e\r\n \t\u003cli\u003eAortic disease diagnosis and treatment\u003c\/li\u003e\r\n \t\u003cli\u003eValvular heart disease in young women\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e💊 Pharmacologic \u0026amp; Preventive Therapies\u003c\/h4\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLipid-lowering therapies (PCSK9 inhibitors, inclisiran, etc.)\u003c\/li\u003e\r\n \t\u003cli\u003eCKM syndrome treatments (finerenone, semaglutide)\u003c\/li\u003e\r\n \t\u003cli\u003eHormone therapy considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e⚙️ Advanced \u0026amp; Interventional Therapies\u003c\/h4\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePercutaneous valve repair techniques\u003c\/li\u003e\r\n \t\u003cli\u003eRenal denervation for resistant hypertension\u003c\/li\u003e\r\n \t\u003cli\u003eBaroreflex activation therapy for heart failure\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e📚 Course Topics Include\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAortic disease in women\u003c\/li\u003e\r\n \t\u003cli\u003eAtrial fibrillation ablation\u003c\/li\u003e\r\n \t\u003cli\u003eMitral and tricuspid valve repair differences\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular-kidney-metabolic (CKM) syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eAcute coronary syndromes in pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eCardiac amyloidosis\u003c\/li\u003e\r\n \t\u003cli\u003eHypertrophic cardiomyopathy\u003c\/li\u003e\r\n \t\u003cli\u003eASCVD prevention and risk assessment\u003c\/li\u003e\r\n \t\u003cli\u003eChronic venous insufficiency\u003c\/li\u003e\r\n \t\u003cli\u003eHypertension and renal denervation\u003c\/li\u003e\r\n \t\u003cli\u003eLipid-lowering therapies updates\u003c\/li\u003e\r\n \t\u003cli\u003eHeart failure management in women\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e⚡ Key Benefits\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eUnderstand \u003cstrong\u003egender-specific cardiovascular disease patterns\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eImprove \u003cstrong\u003ediagnosis and treatment in women\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eApply \u003cstrong\u003elatest guidelines and therapies\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eReduce disparities in cardiovascular care\u003c\/li\u003e\r\n \t\u003cli\u003eEnhance \u003cstrong\u003eclinical decision-making in complex cases\u003c\/strong\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e🚀 Why Choose This Course\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFocused exclusively on \u003cstrong\u003ecardiovascular disease in women\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eCovers \u003cstrong\u003emodern pharmacologic and interventional therapies\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eCase-based discussions for \u003cstrong\u003ereal-world application\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eIdeal for clinicians seeking \u003cstrong\u003eupdated cardiology insights\u003c\/strong\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch3\u003e💡 Clinical Value\u003c\/h3\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis course is essential for healthcare providers who want to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDeliver \u003cstrong\u003epersonalized, gender-specific cardiovascular care\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eStay current with \u003cstrong\u003erapidly evolving cardiology treatments\u003c\/strong\u003e\n\u003c\/li\u003e\r\n \t\u003cli\u003eImprove outcomes for \u003cstrong\u003efemale patients with cardiovascular disease\u003c\/strong\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nl title in this course\r\n\u003ctable\u003e\r\n\u003cthead\u003e\r\n\u003ctr\u003e\r\n\u003cth\u003e\u003cstrong\u003eTitle\u003c\/strong\u003e\u003c\/th\u003e\r\n\u003cth\u003e\u003cstrong\u003eRuntime\u003c\/strong\u003e\u003c\/th\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/thead\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eAortic Disease in Women: Diagnosis and Treatment\u003c\/td\u003e\r\n\u003ctd\u003e22:47\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eAtrial Fibrillation Ablation in Women\u003c\/td\u003e\r\n\u003ctd\u003e22:39\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eSex Differences in Percutaneous Repair of Mitral and Tricuspid Valves\u003c\/td\u003e\r\n\u003ctd\u003e24:04\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eFinerenone and Semaglutide for the Treatment of Cardiovascular-Kidney-Metabolic (CKM) Syndrome\u003c\/td\u003e\r\n\u003ctd\u003e21:23\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eAcute Coronary Syndromes in Pregnancy\u003c\/td\u003e\r\n\u003ctd\u003e20:48\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eTherapeutic Options for Valvular Heart Disease in Young Women\u003c\/td\u003e\r\n\u003ctd\u003e19:32\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eDiagnosis and Treatment of Cardiac Amyloidosis in Women\u003c\/td\u003e\r\n\u003ctd\u003e24:09\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eDiagnosis and Management of Hypertrophic Cardiomyopathy in Women\u003c\/td\u003e\r\n\u003ctd\u003e22:28\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003ePrimary Prevention of ASCVD and Risk Assessment in Women\u003c\/td\u003e\r\n\u003ctd\u003e16:02\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eManagement of Chronic Venous Insufficiency\u003c\/td\u003e\r\n\u003ctd\u003e15:04\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eTreatment of Hypertension: Role of Renal Denervation in Resistant Hypertension\u003c\/td\u003e\r\n\u003ctd\u003e18:01\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eNew (and Traditional) Lipid Lowering Agents: Ezetimibe, PCSK9 Inhibitors, Inclisiran, Evanicumab, Bempedoic Acid\u003c\/td\u003e\r\n\u003ctd\u003e21:20\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eBaroreflex Activation Therapy (BAT) for Heart Failure with Reduced Ejection Fraction (HFrEF)\u003c\/td\u003e\r\n\u003ctd\u003e12:40\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eUpdates in Medical Therapy for Heart Failure in Women\u003c\/td\u003e\r\n\u003ctd\u003e19:50\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eCardiovascular Disease in Women: 2025 Update\u003c\/td\u003e\r\n\u003ctd\u003e27:41\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch1 class=\"product-title product_title entry-title\"\u003e\u003c\/h1\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":42954715201634,"sku":"MED-AMB08709","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Complete-Conference-Management-8th-Annual-Symposium-Contemporary-Management-of-Cardiovascular-Disease-in-Women-2025.jpg?v=1779383005","url":"https:\/\/meducourse.com\/products\/8th-annual-symposium-contemporary-management-of-cardiovascular-disease-in-women-2025","provider":"Meducourse","version":"1.0","type":"link"}